Please assess the completion status of the following clinical trial:

Trial Title: Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* High risk patients - Two to three of the following: PSA 10-30 ng/mL, Gleason score greater than or equal to 6, clinical stage greater than or equal to T2c (2002 ACJJ).~* CT of the abdomen and pelvis and bone scan without evidence of metastases.~* An enzymatic prostatic acid phosphatase must be obtained prior to randomization.~* A serum testosterone must be obtained prior to initiation of androgen deprivation therapy.~* No prior pelvic external beam radiation therapy for prostate cancer or other malignancies.~* No prior androgen deprivation therapy.~* Minimum 5 year life expectancy.~* No other invasive cancer diagnosis other than non-melanoma skin cancer within the last 5 years.~Exclusion Criteria:~* Exclusion criteria will be limited to patients who do not meet the above eligibility criteria.

- Gender: MALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- no hormones (Type: ACTIVE_COMPARATOR): All patients will receive a 5-week course of external beam radiation therapy to the pelvis and a Pd-103 brachytherapy implant with no hormones
- 9 months of hormone therapy (Type: ACTIVE_COMPARATOR): All patients will receive a 5-week course of external beam radiation therapy to the pelvis and a Pd-103 brachytherapy implant with a 9 month course of hormone therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).